Heart Biomarker Evaluation in Apnea Treatment

Completed · Phase 2

Conditions studied: Cardiovascular Disease, Obstructive Sleep Apnea, Coronary Artery Disease

In brief

This study examines the role of sleep apnea treatment in improving cardiovascular biomarkers.

Key facts

Study ID

NCT01086800

Run by

Brigham and Women's Hospital

People needed

318

Starts

2010-02-01

Expected to finish

2012-08-01

Last updated by the study team

2013-02-25

Who can join

Age: 45 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• established Coronary Artery Disease or established cardiovascular disease risk factors
• home sleep test that showed moderately severe sleep apnea

You may not qualify if…

• poorly controlled health
• currently using supplemental oxygen or PAP for OSA

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States
• Partners HealthCare — Boston, Massachusetts, United States
• VA Boston Healthcare System — Boston, Massachusetts, United States
• Case Western Reserve University — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.